PAK1 activation also stimulates anti-apoptotic pathways, such as the Pak-Raf1-Bad [20], [21] and NFκB [20] pathways, rendering PAK1 attractive as a cancer therapeutic target [22]. The gene discussed is PAK1; the disease is cancer.